Home business solution Top Ten Global Healthcare Leaders Choose Kneat As Business Validation Solution

Top Ten Global Healthcare Leaders Choose Kneat As Business Validation Solution

0



LIMERICK, Ireland, 22 December 2021 / CNW / – kneat.com, inc. (TSX: KSI) (“Kneat” or “the Company”), a leader in digitizing and automating validation and quality processes, is pleased to announce that another industry-leading company has chosen Kneat as their enterprise validation platform.

kneat.com, inc. (CNW Group / kneat.com, inc.)

The global biopharmaceutical company based in Europe employs more than 80,000 people, operates in more than 70 countries and currently uses Kneat at 11 of its more than 50 manufacturing sites. Within these 11 locations, this client extended the use of Kneat’s software to several validation processes across major business units, including specialty care, vaccines, and general drugs.

With the signing of this three-year Framework Services Agreement, Kneat has been officially named as the Customer’s Enterprise Validation Solution, enabling them to extend their use of Kneat efficiently and quickly across the organization. .

“We are very pleased that this global leader, one of the world’s most respected healthcare brands, has put more trust in Kneat,” said Eddie ryan, CEO of Kneat. “Their expansion provides further proof of Kneat’s product leadership in the category. “

Kneat continues to grow its diverse customer base, ranging from small biotech companies to leading pharmaceutical companies. Among its clients, Kneat now has master service agreements with 7 of the world’s 10 largest life science companies. The trend of major world leaders to use Kneat in their organization continues.

About Kneat

Kneat, a Canadian company with operational headquarters in Limerick, Ireland, develops and markets the next generation Kneat Gx software platform. Several business work processes can be configured on the platform, from equipment and IT system validation to quality document management. Kneat’s software enables users to create, review, approve, run tests online, manage exceptions, and publish final deliverables in a controlled platform that complies with FDA 21 CFR Part 11 / Eudralex Annex 11. Macro and micro report dashboards enable powerful monitoring of all systems, projects and processes on a global scale. Customer case studies report productivity improvements of over 100% and a higher standard of data integrity and compliance. For more information visit www.kneat.com.

Cautions and forward-looking statements

With the exception of the statements of historical fact contained in this document, certain information presented constitutes “forward-looking information” within the meaning of applicable Canadian securities laws. This forward-looking information includes, but is not limited to, the relationship between Kneat and the customer, Kneat’s business development activities, the timeframes for using and implementing Kneat’s software as part of the customer’s validation processes. , the ability and intent of the client to tailor the use of Kneat’s software within the client’s organization and the compliance of Kneat’s platform for regulatory audits and inspections. While these forward-looking statements are expressed by Kneat, as set forth in this press release, in good faith and considered by Kneat to have a reasonable basis, they are subject to significant risks and uncertainties. As a result of these risks and uncertainties, the events predicted in these forward-looking statements may differ materially from actual results or events. These forward-looking statements are not guarantees of future performance, as they involve risks and uncertainties. The forward-looking information contained in this press release does not include a full assessment or reflection of the unprecedented impacts of the COVID-19 pandemic occurring since the first quarter of 2020 and of the ongoing and developing global and regional indirect economic impacts that result. This has resulted in significant economic uncertainty and while the company has not to date suffered any significant impact on its operations, any potential impact on our future is difficult to understand or measure at this time. Kneat does not undertake any obligation to publish revisions to any forward-looking statement, except as may be required by applicable securities laws. Investors should not assume that the failure to update a previously published forward-looking statement constitutes a reaffirmation of that statement. Continued reliance on forward-looking statements is at the risk and peril of the investors.

SOURCE kneat.com, inc.

Cision

Cision

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/December2021/22/c3603.html